Showing results (251-260 of 316) with videos related to

Sort By:
Pageof 32
Plos One|August 4, 2011
Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosisClaudio Sorio, Mario Buffelli, Chiara Angiari, et al.
Chemical Communications (Cambridge, England)|January 13, 2021
Ion mobility-mass spectrometry shows stepwise protein unfolding under alkaline conditionsCagla Sahin, Nicklas Österlund, Axel Leppert, et al.
ACS Chemical Neuroscience|January 24, 2019
Amyloid-β Peptide Targeting Peptidomimetics for Prevention of NeurotoxicityDmytro Honcharenko, Alok Juneja, Firoz Roshan, et al.
Organic & Biomolecular Chemistry|July 18, 2014
Synthesis and evaluation of antineurotoxicity properties of an amyloid-β peptide targeting ligand containing a triamino acidDmytro Honcharenko, Partha Pratim Bose, Jyotirmoy Maity, et al.
BMC Cancer|January 5, 2017
Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort studyHuan Song, Fang Fang, Unnur Valdimarsdóttir, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 12, 2025
APOE-Targeted Therapeutics for Alzheimer's DiseaseHussein N Yassine, Cristelle Hugo, Bernadette O'Donovan, et al.
Molecular & Cellular Proteomics : MCP|September 17, 2022
Mass Spectrometry and Machine Learning Reveal Determinants of Client Recognition by Antiamyloid ChaperonesNicklas Österlund, Thibault Vosselman, Axel Leppert, et al.
Communications Biology|May 8, 2023
Short hydrophobic loop motifs in BRICHOS domains determine chaperone activity against amorphous protein aggregation but not against amyloid formationGefei Chen, Axel Leppert, Helen Poska, et al.
Nature Communications|March 25, 2016
Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formationPaolo Arosio, Thomas C T Michaels, Sara Linse, et al.
Kidney & Blood Pressure Research|March 23, 2018
Apabetalone Mediated Epigenetic Modulation is Associated with Favorable Kidney Function and Alkaline Phosphatase Profile in Patients with Chronic Kidney DiseaseEwelina Kulikowski, Christopher Halliday, Jan Johansson, et al.
Pageof 32